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BACKGROUND:   
Swiss health insurance regulation has limited the reimbursement of organised 
screening mammography to a period of 10 years, ending in December 2007.  
Continued reimbursement of this screening test within a programme necessitated the 
most comprehensive analysis of breast cancer screening ever performed in 
Switzerland. 
 
OBJECTIVES:   
To extensively evaluate all Swiss regional screening programmes and to compare 
prognostic indicators between screened and unscreened women, both within and 
outside regions covered by a programme. 
 
METHODS: 
Performance of regional programmes were assessed according to European 
Guidelines. Detection and screening modalities (organised vs opportunistic screening, 
no screening, interval cancers) were obtained by data matching with population-based 
Swiss cancer registries. Analyses focussed on the 3 oldest programmes (Geneva, 
Vaud and Wallis) which, although very similar in their organization, had different 
reading strategies. 
 
RESULTS: 
Screening performances met most European standards and a substantial breast 
cancer stage shifting was observed. Most of the variations in performances across 
programmes could be ascribed to reading strategies. Opportunistic and organised 
screening yielded little difference in prognostic profile in regions which offered 
organised screening. Breast cancer prognostic indicators were systematically more 
favourable in Swiss regions covered by a programme. In regions without a screening 
programme, the higher the prevalence of opportunistic screening, the better the 
prognostic profile.  
 
CONCLUSION: 
Mammography screening has influenced the stage distribution of breast cancer in 
Switzerland, and a favourable impact on mortality is anticipated. Organised screening 
was as effective as opportunistic screening, a finding that to date only few studies 
have been able to explore. Extension of organised mammography screening to the 
whole of Switzerland is warranted. 
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